BillionToOne, Inc. (BLLN) stock
BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$105.15−5.64 (-5.09%)
Close on Nov 13, 2026Market cap $4.96BP/E –Yield –
BillionToOne EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
BillionToOne's EPS for the twelve months ending Sep 30, 2025 was -$1.44. For fiscal 2025 it was $0.14.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0.14 | – |
| FY2024 | Dec 31, 2024 | -$4.12 | – |
| FY2023 | Dec 31, 2023 | -$8.45 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $0.32 | – |
| Q2 FY2026 | Jun 30, 2026 | $0.15 | – |
| Q1 FY2026 | Mar 31, 2026 | $0.34 | – |
| Q3 FY2025 | Sep 30, 2025 | $0.10 | – |
| Q2 FY2025 | Jun 30, 2025 | -$0.02 | – |
| Q1 FY2025 | Mar 31, 2025 | -$0.39 | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.13 | – |
| Q3 FY2024 | Sep 30, 2024 | -$1.47 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?